Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
7.12
+0.05 (0.71%)
Sep 2, 2026, 12:45 PM EDT - Market open

Entrada Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
99.2890.39101.2167.645.16291.06
Short-Term Investments
123.73205.3318.79284.37143.56-
Cash & Short-Term Investments
223.01295.7420351.97188.71291.06
Cash Growth
-37.01%-29.59%19.33%86.51%-35.16%645.46%
Accounts Receivable
0.821.183.685.88--
Other Receivables
0.91.41.81.70.6-
Receivables
1.722.585.487.580.6-
Prepaid Expenses
7.987.3214.5610.2220.567.64
Restricted Cash
-0.66----
Total Current Assets
232.7306.25440.04369.77209.88298.7
Property, Plant & Equipment
62.7667.7682.0592.6833.026.26
Other Long-Term Assets
3.413.364.236.749.160.87
Total Assets
298.88377.38526.32469.19252.06305.83

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.752.294.263.285.990.71
Accrued Expenses
12.3316.5112.310.327.155.53
Current Portion of Leases
4.454.147.567.918.41-
Current Income Taxes Payable
--0.674.02--
Current Unearned Revenue
0.170.3413.65132.26--
Other Current Liabilities
0.671.171.0410.430.49
Total Current Liabilities
21.3724.4539.48158.821.976.72
Long-Term Leases
44.146.7951.6560.3217.53-
Long-Term Unearned Revenue
--6.517.72--
Other Long-Term Liabilities
-----0.4
Total Liabilities
65.4771.2597.64226.8339.57.12

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-In Capital
588.92578.57558.06437.13402.89392.38
Retained Earnings
-355.57-273.09-129.34-194.97-188.29-93.67
Comprehensive Income & Other
0.070.65-0.040.2-2.06-
Total Common Equity
233.41306.13428.68242.36212.55298.72
Shareholders' Equity
233.41306.13428.68242.36212.55298.72
Total Liabilities & Equity
298.88377.38526.32469.19252.06305.83

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
48.5450.9359.2168.2325.94-
Net Cash (Debt)
174.46244.77360.79283.74162.78291.06
Net Cash Growth
-41.70%-32.16%27.16%74.31%-44.08%645.46%
Net Cash Per Share
4.185.929.258.595.2046.44
Filing Date Shares Outstanding
36.063635.6332.3333.0831.25
Total Common Shares Outstanding
36.063635.6132.1731.3931.22
Working Capital
211.33281.8400.56210.98187.9291.98
Book Value Per Share
6.478.5012.047.536.779.57
Tangible Book Value
233.41306.13428.68242.36212.55298.72
Tangible Book Value Per Share
6.478.5012.047.536.779.57
Machinery
16.2217.0618.4215.268.546.12
Construction In Progress
----0.58-
Leasehold Improvements
0.190.191.931.861.861.56
SEC Filings: 10-K · 10-Q